Mucosolvan Schleimlöser (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucosolvan Schleimlöser, is a mucolytic agent presented as an oral formulation for oral use. It is used to facilitate the clearance of mucus in respiratory conditions such as acute and chronic bronchitis, bronchopulmonary infections, and chronic obstructive pulmonary disease with mucus hypersecretion.

GNH USA supplies Mucosolvan Schleimlöser as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution.

Ambroxol Hydrochloride acts as a mucolytic and expectorant in disorders characterized by thickened respiratory secretions. - Acute bronchitis: helps loosen mucus, improving cough clearance. - Chronic bronchitis: reduces mucus viscosity, facilitating expectoration in long‑term productive cough. - COPD with mucus hypersecretion: aids in clearing airway secretions and may improve breathing comfort. - Bronchopulmonary infections: supports mucus clearance, assisting the body’s defense mechanisms.

Adverse reactions to Ambroxol Hydrochloride are generally uncommon but may occur.

Common Side Effects: - Nausea: mild stomach upset. - Diarrhea: loose stools. - Taste disturbance: altered taste perception. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or anaphylaxis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes. - Hematologic abnormalities: eosinophilia or leukopenia.

When using Ambroxol Hydrochloride, certain precautions should be observed to ensure safety. - Assess renal function: dose may need adjustment in severe renal impairment. - Monitor hepatic function: use with caution in patients with liver disease. - Avoid in known hypersensitivity: discontinue if allergic signs appear. - Use with caution in asthma: may provoke bronchospasm in susceptible individuals. - Pregnancy and lactation: consult healthcare professional; safety data limited. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Ambroxol Hydrochloride can interact with certain medicines, influencing their effects or safety.

Major Interactions (Avoid): - Anticholinergic agents: may reduce mucociliary clearance, diminishing therapeutic benefit. - Bronchodilators (high-dose β2‑agonists): concurrent use may increase risk of tachycardia.

Moderate Interactions (Monitor Closely): - CYP2D6 substrates: ambroxol may inhibit metabolism, raising plasma levels of drugs such as metoprolol. - Anticoagulants (warfarin): monitor INR as ambroxol could affect bleeding risk. - NSAIDs: combined use may increase gastrointestinal irritation.